A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA-Reference-Cited by-同舟云学术

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

Published:2005-01 Issue:1 Volume:173 Page:48-51
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

SORBELLINI MAXIMILIANO¹,KATTAN MICHAEL W.¹,SNYDER MARK E.¹,REUTER VICTOR¹,MOTZER ROBERT¹,GOETZL MANLIO¹,McKIERNAN JAMES¹,RUSSO PAUL¹

Affiliation:

1. From the Departments of Urology (MS, MWK, MES, RM, PR), Pathology (VR), and Epidemiology and Biostatistics (MWK), Memorial Sloan-Kettering Cancer Center, and the Department of Urology, Columbia University (MG, JM), New York, New York

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 443 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer;Frontiers in Oncology;2024-02-02

2. Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib;Biomedicines;2024-01-10

3. Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma;Advances in Anatomic Pathology;2024-01-05

4. Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database;Journal of Korean Medical Science;2024

5. Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC;International Journal of Molecular Sciences;2023-12-22